Former FDA commissioners slam Prasad’s plan for ‘sweeping’ vaccine changesnews2025-12-03T22:00:34+00:00December 3rd, 2025|Endpoints News|
FDA seeks to raise user fees for companies running Phase 1 trials outside the USnews2025-12-03T20:00:14+00:00December 3rd, 2025|Endpoints News|
FDA says it won’t release details of claimed Covid vaccine deaths in ‘near term’news2025-12-03T18:07:40+00:00December 3rd, 2025|Endpoints News|
With Phase 3 Duchenne success, Capricor plots path forward after FDA rejectionnews2025-12-03T16:36:07+00:00December 3rd, 2025|Endpoints News|
FDA to remove some monkey testing from monoclonal antibody developmentnews2025-12-02T19:42:33+00:00December 2nd, 2025|Endpoints News|
Pazdur’s exit at FDA has biotech afraid of agency ‘tipping point’news2025-12-02T16:33:34+00:00December 2nd, 2025|Endpoints News|
House passes bill to reauthorize rare pediatric PRV program; Senate nextnews2025-12-02T03:29:54+00:00December 2nd, 2025|Endpoints News|
New ACIP chair claims Covid-19 vaccines caused cancer, miscarriagesnews2025-12-01T21:23:50+00:00December 1st, 2025|Endpoints News|
FDA and Prasad’s Covid vaccine death claims lack key detailsnews2025-12-01T20:24:17+00:00December 1st, 2025|Endpoints News|
Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS saysnews2025-11-26T19:14:48+00:00November 26th, 2025|Endpoints News|
